These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 28916075)
1. Dose-dependent effects of ivabradine on heart rate during maximal efforts in a woman with permanent atrial fibrillation. Fossati C; Volterrani M; Punzo N; Campolongo G; Cascelli G; Caminiti G Int J Cardiol; 2017 Nov; 247():37. PubMed ID: 28916075 [No Abstract] [Full Text] [Related]
2. Emerging role of ivabradine for rate control in atrial fibrillation. Turley SL; Francis KE; Lowe DK; Cahoon WD Ther Adv Cardiovasc Dis; 2016 Dec; 10(6):348-352. PubMed ID: 27659287 [TBL] [Abstract][Full Text] [Related]
3. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation. Verrier RL; Bonatti R; Silva AF; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L Heart Rhythm; 2014 Dec; 11(12):2288-96. PubMed ID: 25111327 [TBL] [Abstract][Full Text] [Related]
4. Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance. Caminiti G; Fossati C; Rosano G; Volterrani M Int J Cardiol; 2016 Jan; 202():73-4. PubMed ID: 26386926 [No Abstract] [Full Text] [Related]
5. Might ivabradine be useful in permanent atrial fibrillation? Moubarak G; Logeart D; Cazeau S; Cohen Solal A Int J Cardiol; 2014 Jul; 175(1):187-8. PubMed ID: 24814540 [No Abstract] [Full Text] [Related]
6. Ivabradine for rate control in atrial fibrillation. Kosiuk J; Oebel S; John S; Hilbert S; Hindricks G; Bollmann A Int J Cardiol; 2015 Jan; 179():27-8. PubMed ID: 25464400 [No Abstract] [Full Text] [Related]
7. Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs. Uemura K; Inagaki M; Zheng C; Kawada T; Li M; Fukumitsu M; Sugimachi M Heart Vessels; 2017 Apr; 32(4):484-494. PubMed ID: 27844147 [TBL] [Abstract][Full Text] [Related]
8. Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation. Wongcharoen W; Ruttanaphol A; Gunaparn S; Phrommintikul A Int J Cardiol; 2016 Dec; 224():252-255. PubMed ID: 27661415 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation. Verrier RL; Sobrado MF; Pagotto VP; Kanas AF; Machado AD; Varone BB; Sobrado LF; Nearing BD; Zeng D; Belardinelli L Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296 [TBL] [Abstract][Full Text] [Related]
10. Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation. Verrier RL; Silva AF; Bonatti R; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L J Cardiovasc Electrophysiol; 2015 Mar; 26(3):329-35. PubMed ID: 25346368 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Camm AJ; Lau CP Drugs R D; 2003; 4(2):83-9. PubMed ID: 12718562 [TBL] [Abstract][Full Text] [Related]
12. Ivabradine as an Alternative to AV Node Ablation in a Patient With Permanent Atrial Fibrillation. Fontenla A; Villagraz L; de Juan J; Lozano Á; Giacoman S; López-Gil M Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):1019-1020. PubMed ID: 28522303 [No Abstract] [Full Text] [Related]
13. Atrial Fibrillation After Coronary Artery Bypass Surgery: Can Ivabradine Reduce Its Occurrence? Abdel-Salam Z; Nammas W J Cardiovasc Electrophysiol; 2016 Jun; 27(6):670-6. PubMed ID: 27006322 [TBL] [Abstract][Full Text] [Related]
14. A case of atrial tachycardia treated with ivabradine as bridge to ablation. Meles E; Carbone C; Maggiolini S; Moretti P; DE Carlini CC; Gentile G; Gnecchi-Ruscone T J Cardiovasc Electrophysiol; 2015 May; 26(5):565-8. PubMed ID: 25656911 [TBL] [Abstract][Full Text] [Related]
15. Ivabradine and atrial fibrillation: what should we tell our patients? Cowie MR Heart; 2014 Oct; 100(19):1487-8. PubMed ID: 24986893 [No Abstract] [Full Text] [Related]
16. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study. Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I; J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188 [TBL] [Abstract][Full Text] [Related]
17. Metoprolol vs ivabradine in patients with mitral stenosis in sinus rhythm. Agrawal V; Kumar N; Lohiya B; Sihag BK; Prajapati R; Singh TB; Subramanian G Int J Cardiol; 2016 Oct; 221():562-6. PubMed ID: 27420578 [TBL] [Abstract][Full Text] [Related]
19. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. Ruzyllo W; Tendera M; Ford I; Fox KM Drugs; 2007; 67(3):393-405. PubMed ID: 17335297 [TBL] [Abstract][Full Text] [Related]
20. Effect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With Metoprolol. Saggu DK; Narain VS; Dwivedi SK; Sethi R; Chandra S; Puri A; Saran RK J Cardiovasc Pharmacol; 2015 Jun; 65(6):552-4. PubMed ID: 25636072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]